CliffBio

Vanda Pharmaceuticals

Patent cliffs & loss of exclusivity

A biopharmaceutical company developing and commercializing products to treat central nervous system disorders

Company

AngelList URLhttps://angel.co/vanda-pharmaceuticals
CAGE Code68U09
Legal NameVanda Pharmaceuticals, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/vanda-pharmaceuticals
Fax Number202-296-1450
Full Address2200 PENNSYLVANIA AVE NW STE 300E WASHINGTON, DC 20037 UNITED STATES
LinkedIn URLhttps://www.linkedin.com/company/vanda-pharmaceuticals/

19 upcoming patent cliffs

DrugIngredientTypeCliff
  1. FANAPTILOPERIDONESmall mol.Dec 2031
  2. FANAPTILOPERIDONESmall mol.Dec 2031
  3. FANAPTILOPERIDONESmall mol.Dec 2031
  4. FANAPTILOPERIDONESmall mol.Dec 2031
  5. FANAPTILOPERIDONESmall mol.Dec 2031
  6. FANAPTILOPERIDONESmall mol.Dec 2031
  7. FANAPTILOPERIDONESmall mol.Dec 2031
  8. NEREUSTRADIPITANTSmall mol.Aug 2036
  9. HETLIOZTASIMELTEONSmall mol.Feb 2041
  10. HETLIOZ LQTASIMELTEONSmall mol.Feb 2041
  11. BYSANTIMILSAPERIDONESmall mol.May 2044
  12. BYSANTIMILSAPERIDONESmall mol.May 2044
  13. BYSANTIMILSAPERIDONESmall mol.May 2044
  14. BYSANTIMILSAPERIDONESmall mol.May 2044
  15. BYSANTIMILSAPERIDONESmall mol.May 2044
  16. BYSANTIMILSAPERIDONESmall mol.May 2044
  17. BYSANTIMILSAPERIDONESmall mol.May 2044
  18. PONVORYPONESIMODSmall mol.Dec 2044
  19. PONVORYPONESIMODSmall mol.Dec 2044

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.